Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study).

Palmieri LJ, Mineur L, Tougeron D, Rousseau B, Granger V, Gornet JM, Smith D, Lievre A, Galais MP, Doat S, Pernot S, Bignon-Bretagne AL, Metges JP, Baba-Hamed N, Michel P, Obled S, Vitellius C, Bouche O, Saban-Roche L, Buecher B, des Guetz G, Locher C, Trouilloud I, Goujon G, Dior M, Manfredi S, Soularue E, Phelip JM, Henriques J, Vernery D, Coriat R.

Oncologist. 2019 Oct 2. pii: theoncologist.2019-0328. doi: 10.1634/theoncologist.2019-0328. [Epub ahead of print]

PMID:
31578276
2.

Circulating neutrophil and eosinophil extracellular traps are markers of severe asthma.

Granger V, Taillé C, Roach D, Letuvé S, Dupin C, Hamidi F, Noël B, Neukirch C, Aubier M, Pretolani M, Chollet-Martin S, de Chaisemartin L.

Allergy. 2019 Sep 24. doi: 10.1111/all.14059. [Epub ahead of print] No abstract available.

PMID:
31549729
3.

Nrf2 downregulates zymosan-induced neutrophil activation and modulates migration.

Helou DG, Braham S, De Chaisemartin L, Granger V, Damien MH, Pallardy M, Kerdine-Römer S, Chollet-Martin S.

PLoS One. 2019 Aug 16;14(8):e0216465. doi: 10.1371/journal.pone.0216465. eCollection 2019.

4.

An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis.

Jönsson F, de Chaisemartin L, Granger V, Gouel-Chéron A, Gillis CM, Zhu Q, Dib F, Nicaise-Roland P, Ganneau C, Hurtado-Nedelec M, Paugam-Burtz C, Necib S, Keita-Meyer H, Le Dorze M, Cholley B, Langeron O, Jacob L, Plaud B, Fischler M, Sauvan C, Guinnepain MT, Montravers P, Aubier M, Bay S, Neukirch C, Tubach F, Longrois D, Chollet-Martin S, Bruhns P.

Sci Transl Med. 2019 Jul 10;11(500). pii: eaat1479. doi: 10.1126/scitranslmed.aat1479.

PMID:
31292264
5.

Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer.

Ramakrishnan S, Granger V, Rak M, Hu Q, Attwood K, Aquila L, Krishnan N, Osiecki R, Azabdaftari G, Guru K, Chatta G, Gueron G, McNally L, Ohm J, Wang J, Woloszynska A.

Cell Death Differ. 2019 Oct;26(10):2100-2114. doi: 10.1038/s41418-019-0278-9. Epub 2019 Jan 28.

6.

Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related Acute Respiratory Distress Syndrome.

Bendib I, de Chaisemartin L, Granger V, Schlemmer F, Maitre B, Hüe S, Surenaud M, Beldi-Ferchiou A, Carteaux G, Razazi K, Chollet-Martin S, Mekontso Dessap A, de Prost N.

Anesthesiology. 2019 Apr;130(4):581-591. doi: 10.1097/ALN.0000000000002619.

PMID:
30676417
7.

Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process.

Faille D, Bourrienne MC, de Raucourt E, de Chaisemartin L, Granger V, Lacroix R, Panicot-Dubois L, Hammel P, Lévy P, Ruszniewski P, Ajzenberg N, Rebours V.

Oncotarget. 2018 May 29;9(41):26453-26465. doi: 10.18632/oncotarget.25458. eCollection 2018 May 29.

8.

Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).

Zaanan A, Bouché O, Benhaim L, Buecher B, Chapelle N, Dubreuil O, Fares N, Granger V, Lefort C, Gagniere J, Meilleroux J, Baumann AS, Vendrely V, Ducreux M, Michel P; Thésaurus National de Cancérologie Digestive (TNCD).

Dig Liver Dis. 2018 Aug;50(8):768-779. doi: 10.1016/j.dld.2018.04.025. Epub 2018 Jun 6.

PMID:
29886081
9.

Aspergillus-induced pneumonia in adult without obvious immunodeficiency: test the burst!

Flament H, Granger V, Vezinet C, Marzaioli V, Kannengiesser C, de Chaisemartin L, Hurtado-Nedelec M, Litvinova E, Messika J, Adam N, Gougerot-Pocidalo MA, Dang PM, Monteiro R, El Benna J, Langeron O, Chollet-Martin S, Monsel A.

Eur Respir J. 2018 Apr 26;51(4). pii: 1702711. doi: 10.1183/13993003.02711-2017. Print 2018 Apr. No abstract available.

10.

Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study.

Walter T, Malka D, Hentic O, Lombard-Bohas C, Le Malicot K, Smith D, Ferru A, Assenat E, Cadiot G, Lievre A, Kurtz JE, Dahan L, Dubreuil O, Hautefeuille V, Lepere C, Gangloff A, Elhajbi F, Coriat R, Roquin G, Bouarioua N, Granger V, Scoazec JY, Lepage C.

Dig Liver Dis. 2018 Feb;50(2):195-198. doi: 10.1016/j.dld.2017.11.020. Epub 2017 Dec 6.

PMID:
29258812
11.

Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.

Ramakrishnan S, Hu Q, Krishnan N, Wang D, Smit E, Granger V, Rak M, Attwood K, Johnson C, Morrison C, Pili R, Chatta G, Guru K, Gueron G, McNally L, Wang J, Woloszynska-Read A.

Cell Death Dis. 2017 Dec 14;8(12):3217. doi: 10.1038/s41419-017-0024-5.

12.

Patient-reported tolerance in treatments approved in neuroendocrine tumors: A national survey from the French Group of Endocrine Tumors.

Plante A, Baudin E, Do Cao C, Hentic O, Dubreuil O, Terrebonne E, Granger V, Smith D, Lombard-Bohas C, Walter T.

Clin Res Hepatol Gastroenterol. 2018 Apr;42(2):153-159. doi: 10.1016/j.clinre.2017.10.003. Epub 2017 Nov 20.

PMID:
29158141
13.

Low end-tidal CO2 as a real-time severity marker of intra-anaesthetic acute hypersensitivity reactions.

Gouel-Chéron A, de Chaisemartin L, Jönsson F, Nicaise-Roland P, Granger V, Sabahov A, Guinnepain MT, Chollet-Martin S, Bruhns P, Neukirch C, Longrois D; NASA study group.

Br J Anaesth. 2017 Nov 1;119(5):908-917. doi: 10.1093/bja/aex260.

14.

Human blood monocytes are able to form extracellular traps.

Granger V, Faille D, Marani V, Noël B, Gallais Y, Szely N, Flament H, Pallardy M, Chollet-Martin S, de Chaisemartin L.

J Leukoc Biol. 2017 Sep;102(3):775-781. doi: 10.1189/jlb.3MA0916-411R. Epub 2017 May 2.

PMID:
28465447
15.

Neutrophil expression of glucocorticoid-induced leucine zipper (GILZ) anti-inflammatory protein is associated with acute respiratory distress syndrome severity.

Espinasse MA, Hajage D, Montravers P, Piednoir P, Dufour G, Tubach F, Granger V, de Chaisemartin L, Noël B, Pallardy M, Chollet-Martin S, Biola-Vidamment A.

Ann Intensive Care. 2016 Dec;6(1):105. doi: 10.1186/s13613-016-0210-0. Epub 2016 Nov 2.

16.

OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?

Faille D, Ajzenberg N, de Chaisemartin L, Granger V, Chollet-Martin S, de Raucourt E, Hammel P, Lévy P, Ruszniewski P, Rebours V.

Thromb Res. 2016 Apr;140 Suppl 1:S170-1. doi: 10.1016/S0049-3848(16)30123-2. Epub 2016 Apr 8.

PMID:
27161678
17.

Long-term therapy with bevacizumab in a patient with Glanzmann's thrombasthenia and recurrent digestive bleeding due to gastrointestinal angiodysplastic lesions.

Marlu R, Barthelon J, Durand A, Mathieu N, Barro C, Granger V, Tatu A, Pernod G, Polack B, Bonaz B.

Am J Gastroenterol. 2015 Feb;110(2):352-3. doi: 10.1038/ajg.2014.391. No abstract available.

PMID:
25646919
18.

[Miraculous catch by neutrophils NETs].

Granger V, de Chaisemartin L, Chollet-Martin S.

Med Sci (Paris). 2014 May;30(5):544-9. doi: 10.1051/medsci/20143005018. Epub 2014 Jun 13. Review. French.

19.

Development and evaluation of a stabilized whole-blood preparation as a process control material for screening of paroxysmal nocturnal hemoglobinuria by flow cytometry.

Richards SJ, Whitby L, Cullen MJ, Dickinson AJ, Granger V, Reilly JT, Hillmen P, Barnett D.

Cytometry B Clin Cytom. 2009 Jan;76(1):47-55. doi: 10.1002/cyto.b.20438. Epub 2008 Sep 5.

20.

Long-term stabilized blood samples as controls for flow cytometric HLA-B27 screening: a feasibility study.

Levering WH, Wind H, Granger V, Sintnicolaas K, Hooijkaas H, Reilly JT, Gratama JW, Barnett D.

Cytometry B Clin Cytom. 2008 May;74(3):169-81. doi: 10.1002/cyto.b.20388.

21.

Initial endoscopic description of esophageal squamous cell carcinomas.

Granger V, Assenat E, Barbotte E, Blanc F, Blanc P, Pouderoux P, Ychou M, Senesse P.

Gastroenterol Clin Biol. 2006 Dec;30(12):1365-70.

22.

Flow rate calibration. III. The use of stabilized biostandards to calibrate the flow rate and calculate absolute CD4+ T-cell counts.

Walker CL, Whitby L, Granger V, Storie I, Reilly JT, Barnett D.

Cytometry B Clin Cytom. 2006 May;70(3):154-62.

23.

Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy.

Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P, Felici C, Falcieri E, Reilly JT, Barnett D, Papa S.

J Immunol Methods. 2004 Dec;295(1-2):67-78. Epub 2004 Oct 12.

PMID:
15627612
24.

Diagnosis of plasma cell leukaemia: findings of the UK NEQAS for Leucocyte Immunophenotyping scheme.

van Veen JJ, Reilly JT, Richards SJ, Whitby L, Goodfellow K, Granger V, Rees DC, Barnett D.

Clin Lab Haematol. 2004 Feb;26(1):37-42.

PMID:
14738436
25.

Perfect count: a novel approach for the single platform enumeration of absolute CD4+ T-lymphocytes.

Storie I, Sawle A, Goodfellow K, Whitby L, Granger V, Ward RY, Peel J, Smart T, Reilly JT, Barnett D.

Cytometry B Clin Cytom. 2004 Jan;57(1):47-52.

26.

Flow rate calibration II: a clinical evaluation study using PanLeucoGating as a single-platform protocol.

Storie I, Sawle A, Whitby L, Goodfellow K, Granger V, Reilly JT, Barnett D.

Cytometry B Clin Cytom. 2003 Sep;55(1):8-13.

27.

Flow rate calibration I: a novel approach for performing absolute cell counts.

Storie I, Sawle A, Goodfellow K, Whitby L, Granger V, Reilly JT, Barnett D.

Cytometry B Clin Cytom. 2003 Sep;55(1):1-7.

28.

[Prostate cancer and acute disseminated intravascular coagulation. Therapeutic management based on three cases].

Avances C, Oumaya C, Granger V, Dubon O, Gris JC, Culine S, Costa P.

Prog Urol. 2003 Apr;13(2):308-12. French.

PMID:
12765072
29.

Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study.

Gratama JW, Kraan J, Keeney M, Sutherland DR, Granger V, Barnett D.

Cytotherapy. 2003;5(1):55-65.

PMID:
12745591
30.

The United Kingdom National External Quality Assessment Scheme gating and standardization strategy for use in residual WBC counting of WBC-reduced blood components.

Goodfellow KJ, Storie I, Granger V, Whitby L, Antcliffe J, Reilly JT, Barnett D.

Transfusion. 2002 Jun;42(6):738-46.

PMID:
12147027
31.
33.

Affordable CD4+ T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settings.

Jani V, Janossy G, Iqbal A, Mhalu FS, Lyamuya EF, Biberfeld G, Glencross DK, Scott L, Reilly JT, Granger V, Barnett D.

J Immunol Methods. 2001 Nov 1;257(1-2):145-54.

PMID:
11687248
34.

Low level leucocyte counting: a critical variable in the validation of leucodepleted blood transfusion components as highlighted by an external quality assessment study.

Barnett D, Goodfellow K, Ginnever J, Granger V, Whitby L, Reilly JT.

Clin Lab Haematol. 2001 Feb;23(1):43-51.

PMID:
11422230
35.

Standardization of lymphocyte antibody binding capacity - a multi-centre study.

Barnett D, Storie I, Granger V, Whitby L, Reilly JT, Brough S, Garner S, Lawry J, Richards S, Bell AE, Shenton BK.

Clin Lab Haematol. 2000 Apr;22(2):89-96.

PMID:
10792398
37.

Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: the way forward.

Barnett D, Granger V, Whitby L, Storie I, Reilly JT.

Br J Haematol. 1999 Sep;106(4):1059-62.

PMID:
10520014
38.
39.

Determination of leucocyte antibody binding capacity (ABC): the need for standardization.

Barnett D, Storie I, Wilson GA, Granger V, Reilly JT.

Clin Lab Haematol. 1998 Jun;20(3):155-64.

PMID:
9681230
40.
41.

Circulating CD20dim T-lymphocytes increase with age: evidence for a memory cytotoxic phenotype.

Storie I, Wilson GA, Granger V, Barnett D, Reilly JT.

Clin Lab Haematol. 1995 Dec;17(4):323-8.

PMID:
8697727
42.

Leukaemia immunophenotyping: effect of antibody source and fluorochrome on antigen detection.

Reilly JT, Granger V, Temperton PF, Barnett D.

J Clin Pathol. 1995 Feb;48(2):186. No abstract available.

43.

Expression of the p75 interleukin-2 receptor (beta subunit) in acute and chronic leukaemia.

Barnett D, Granger V, Reilly JT.

Br J Haematol. 1990 Oct;76(2):314-5. No abstract available.

PMID:
2094338

Supplemental Content

Loading ...
Support Center